EFFECTS OF 5-HT1A RECEPTOR AGONISTS ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS ACTIVITY AND CORTICOTROPIN-RELEASING FACTOR CONTAINING NEURONS IN THE RAT-BRAIN

被引:70
作者
OWENS, MJ
EDWARDS, E
NEMEROFF, CB
机构
[1] DUKE UNIV,MED CTR,DEPT PSYCHIAT,DIV BIOL PSYCHIAT,BOX 3859,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710
[3] SUNY STONY BROOK,DEPT PSYCHIAT & BEHAV SCI,STONY BROOK,NY 11794
关键词
(Neuroendocrine); 5-HT[!sub]1A[!/sub] receptors; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); CRF (corticotropin-releasing factor); Ipsapirone;
D O I
10.1016/0014-2999(90)94118-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Corticotropin-releasing factor (CRF) is the major physiological regulator of the hypothalamo-pituitary-adrenal axis. There is evidence that CRF release from the hypothalamus is under stimulatory serotonergic control. The specific 5-HT receptor subtypes that mediate this effect is unclear. Administration of the 5-HT1A agonists, 8-OH-DPAT (1 mg/kg) and ipsapirone (4 mg/kg), to rats resulted in activation of the HPA axis as evidenced by increased plasma ACTH and corticosterone concentrations in acutely treated rats and increased plasma corticosterone concentrations in both acutely and chronically treated rats. However, chronic administration of these compounds failed to alter CRF concentrations in the median eminence or CRF receptor number or affinity in the anterior pituitary. Chronic administration of both compounds resulted in increased CRF concentrations in the piriform cortex and hippocampus, whereas 8-OH-DPAT alone increased CRF concentrations in the amygdala and entorhinal cortex. These results suggest that both hypothalamic and extrahypothalamic CRF neurons are influenced by activation of 5-HT1A receptors. © 1990.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 62 条
[1]  
AGHAJANIAN GK, 1978, PSYCHOPHARMACOLOGY G, P183
[2]  
AULAKH CS, 1988, EUROPEAN J PHARM, V156, P398
[3]   IPSAPIRONE DEPRESSES NEURONAL-ACTIVITY IN THE DORSAL RAPHE NUCLEUS AND THE HIPPOCAMPAL-FORMATION [J].
BASSETOMUSK, A ;
REBEC, GV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 130 (1-2) :141-143
[4]   DEXAMETHASONE SUPPRESSES PITUITARY-ADRENAL BUT NOT BEHAVIORAL-EFFECTS OF CENTRALLY ADMINISTERED CRF [J].
BRITTON, DR ;
VARELA, M ;
GARCIA, A ;
ROSENTHAL, M .
LIFE SCIENCES, 1986, 38 (03) :211-216
[5]   CORTICOTROPIN RELEASING-FACTOR (CRF) RECEPTOR ANTAGONIST BLOCKS ACTIVATING AND ANXIOGENIC ACTIONS OF CRF IN THE RAT [J].
BRITTON, KT ;
LEE, G ;
VALE, W ;
RIVIER, J ;
KOOB, GF .
BRAIN RESEARCH, 1986, 369 (1-2) :303-306
[6]   CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J ;
VALE, W .
ENDOCRINOLOGY, 1982, 111 (03) :928-931
[7]   CENTRAL NERVOUS-SYSTEM EFFECTS OF CORTICOTROPIN RELEASING-FACTOR IN THE DOG [J].
BROWN, MR ;
FISHER, LA .
BRAIN RESEARCH, 1983, 280 (01) :75-79
[8]   NEURO-PHARMACOLOGICAL CHARACTERIZATION OF SEROTONINERGIC STIMULATION OF VASOPRESSIN SECRETION IN CONSCIOUS RATS [J].
BROWNFIELD, MS ;
GREATHOUSE, J ;
LORENS, SA ;
ARMSTRONG, J ;
URBAN, JH ;
VANDEKAR, LD .
NEUROENDOCRINOLOGY, 1988, 47 (04) :277-283
[9]   EFFECTS OF SEROTONERGIC AGONISTS AND ANTAGONISTS ON CORTICOTROPIN-RELEASING HORMONE-SECRETION BY EXPLANTED RAT HYPOTHALAMI [J].
CALOGERO, AE ;
BERNARDINI, R ;
MARGIORIS, AN ;
BAGDY, G ;
GALLUCCI, WT ;
MUNSON, PJ ;
TAMARKIN, L ;
TOMAI, TP ;
BRADY, L ;
GOLD, PW ;
CHROUSOS, GP .
PEPTIDES, 1989, 10 (01) :189-200
[10]  
CUMMINGS S, 1983, J NEUROSCI, V3, P1355